Vice President JD Vance announced a new push on Wednesday to create price stability in the market for critical rare earth minerals and said he wants to use a familiar Trump-world tool to accomplish it ...

More than 1 in 8 American adults are using GLP-1’s for weight loss. Experts say these are the nutritional gaps and side effects that should not to be overlooked. As GLP-1 medications continue to ...

Elon Musk's rocket maker SpaceX has acquired artificial intelligence startup xAI in a deal that will value the company at $1.25 trillion, CNBC has confirmed. The transaction comes ahead of a potential ...

Now that generative artificial intelligence tools have been widely implemented in retirement planning, experts suggest advisers turn to embedded AI to ramp up efficiency. Generative artificial ...

Research shows that practicing these two key sleep hygiene roles every night can help you live longer When you purchase through links on our site, we may earn an affiliate commission. Here’s how it ...

Participating Medicare Part D plans can officially begin covering weight-loss treatment in 2027. The initiative falls under CMS’ voluntary “Better Approaches to Lifestyle and Nutrition for ...

Musk could be consolidating his companies. Musk could be consolidating his companies. is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after nearly two years at ...

Long-term GLP-1 use slows medical cost growth, according to findings published Jan. 13 from professional services firm Aon. The firm analyzed 192,000 GLP-1 users from July 2022 to March 2025, ...

Just when you thought the circular deals couldn’t get any more circular, OpenAI has invested in CEO Sam Altman’s brain computer interface (BCI) startup Merge Labs. Merge Labs, which defines itself as ...

On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman. OpenAI will collaborate with the new venture to develop technology to link ...

For women with obesity, GLP-1 medications like Ozempic and Wegovy may help address the metabolic challenges that often intensify during midlife. The hormonal shifts of perimenopause and menopause can ...